CAS: 221877-54-9 - Zotarolimus
Fórmula:C52H79N5O12
InChI:InChI=1S/C52H79N5O12/c1-31-16-12-11-13-17-32(2)43(65-8)28-39-21-19-37(7)52(64,69-39)49(61)50(62)56-23-15-14-18-41(56)51(63)68-44(34(4)26-38-20-22-40(45(27-38)66-9)57-30-53-54-55-57)29-42(58)33(3)25-36(6)47(60)48(67-10)46(59)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-41,43-45,47-48,60,64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,32-17+,36-25+/t31-,33-,34-,35-,37-,38+,39+,40+,41+,43+,44+,45-,47-,48+,52-/m1/s1
Clave InChI:InChIKey=CGTADGCBEXYWNE-JUKNQOCSSA-N
SMILES:O=C1OC(CC(=O)C(C=C(C)C(O)C(OC)C(=O)C(C)CC(C=CC=CC=C(C)C(OC)CC2OC(O)(C(=O)C(=O)N3CCCCC13)C(C)CC2)C)C)C(C)CC4CCC(N5N=NN=C5)C(OC)C4
- Sinónimos:
- (42S)-42-Deoxy-42-(1H-tetrazol-1-yl)rapamycin
- 42-(1-Tetrazolyl)rapamycin
- A 179578
- Abt 578
- Endeavor
- Rapamycin, 42-deoxy-42-(1H-tetrazol-1-yl)-, (42S)-
- Resolute
- Unii-H4gxr80ize
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ZOTAROLIMUS REF: IN-DA00BF84CAS: 221877-54-9 | 95% | A consultar | Mar 07 Ene 25 |
 | Zotarolimus REF: 4Z-Z-141CAS: 221877-54-9 | - - - | A consultar | Mié 08 Ene 25 |
 | Zotarolimus REF: TM-T6033CAS: 221877-54-9 | 95% - ≥98% | 65,00 €~800,00 € | Mar 14 Ene 25 |
| Zotarolimus-d3 REF: 4Z-Z-142CAS: 221877-54-9 | - - - | A consultar | Mar 14 Ene 25 |
 | Zotarolimus REF: 3D-FZ28788CAS: 221877-54-9 | Min. 95% | 136,00 €~723,00 € | Mar 21 Ene 25 |
 | Zotarolimus-d3, >90% (contains d0) REF: TR-Z700802CAS: 221877-54-9 | - - - | 1.566,00 € | Mar 18 Feb 25 |
| Zotarolimus, >90% REF: TR-Z700800CAS: 221877-54-9 | >90% | - - - | Producto descatalogado |
Ref: IN-DA00BF84
| 1mg | 108,00 € | ||
| 5mg | 201,00 € | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Ref: 4Z-Z-141
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
Zotarolimus
CAS:221877-54-9
Zotarolimus (ABT-578), an analogue of rapamycin, inhibits FKBP-12 (IC50= 2.8 nM).
Fórmula:
C52H79N5O12
Pureza:
95% - ≥98%
Forma y color:
Solid
Peso molecular:
966.21
Ref: TM-T6033
| 1mg | 65,00 € | ||
| 2mg | 95,00 € | ||
| 5mg | 142,00 € | ||
| 10mg | 220,00 € | ||
| 25mg | 385,00 € | ||
| 50mg | 555,00 € | ||
| 100mg | 800,00 € | ||
| 1mL*10mM (DMSO) | 237,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Ref: 4Z-Z-142
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Zotarolimus
CAS:221877-54-9
Inhibitor of immunophilin FKBP12 and mTOR signalling with immunosuppressant activity. Zotarolimus inhibits proliferation of endothelial …
Fórmula:
C52H79N5O12
Pureza:
Min. 95%
Forma y color:
White Powder
Peso molecular:
966.21 g/mol
Ref: 3D-FZ28788
| 1mg | 136,00 € | ||
| 2mg | 195,00 € | ||
| 5mg | 303,00 € | ||
| 10mg | 447,00 € | ||
| 25mg | 723,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Zotarolimus-d3, >90% (contains d0)
Producto controladoCAS:221877-54-9
Fórmula:
C52D3H76N5O12
Forma y color:
Neat
Peso molecular:
969.229
Ref: TR-Z700802
| 2500µg | 1.566,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
Zotarolimus, >90%
CAS:221877-54-9
Applications A tetrazole-containing Rapamycin analog as immunomodulator and useful in the treatment of restenosis and …
Fórmula:
C52H79N5O12
Pureza:
>90%
Forma y color:
White to Pale Yellow Solid
Peso molecular:
966.21
Ref: TR-Z700800
| 10mg | Descatalogado | Solicitar información |
